Table 3.
Effects of pretreatment with TAA, silymarin, and ERZO on serum liver biomarkers of experimental rats.
| Animal groups | ALP (IU/L) | ALT (IU/L) | AST (IU/L) | GGT (IU/L) |
|---|---|---|---|---|
| Normal control | 100.67 ± 4.96b | 64 ± 1.26b | 174.5 ± 8.11b | 5 ± 0.00b |
| TAA control | 243.83 ± 18.33a | 209.83 ± 5.23a | 322.16 ± 6.17a | 12 ± 0.00a |
| HD 500 mg/kg | 119.67 ± 3.72ab | 63.83 ± 7.25b | 180.83 ± 1.94b | 6.67 ± 0.55ab |
| LD 250 mg/kg | 218.83 ± 16.58a | 82.5 ± 3.09ab | 227.83 ± 4.62b | 6.83 ± 0.16b |
| Silymarin 50 mg/kg | 132.66 ± 10.44b | 70.3 ± 4.92b | 184.33 ± 7.9b | 7 ± 0.00ab |
Data are expressed as mean ± SEM. Means among groups (n = 6 rats/group) show significant difference.
b P < 0.05 compared to TAA control group, and a P < 0.05 compared to normal control group.